If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Science Liaison
Download FREE Excerpt
11 Info Graphics
19 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Charged with being the chief connection between a company's science and critical stakeholders in the marketplace, Medical Science Liaisons (MSLs) are attracting more attention from pharmaceutical executives. However, both their policy direction and manner in which MSLs interface with key stakeholders are evolving.
Best Practices, LLC conducted this study to investigate the changing role of MSLs in serving their key constituents. This research presents benchmarks around key MSL services within payer education and support, hospital/ health care access, physician education and patient education. Biopharmaceutical and medical device executives can use this study to assess resource allocation of MSLs and key strategies used in MSL interfacing as it evolves in the future.
Note: Data are presented in two segments: The total benchmark class and a U.S. only segment.
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care
Advanced Biohealing; Allergan; Amylin; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Cephalon; EndoPharma; Eisai; Gambro; G.E. Healthcare; Genetech; GlaxoSmithKline; Ironwood Pharma; Kadmon Pharma; Laboratorios Esteve; Lantheus Medical Imaging; Metronic; Merck Sharp and Dohme; Novartis; Novo Nordisk; Onyx Pharma; Pfizer; QLT; Quidel; Shire; Takeda; Theravance; UCB